Thioredoxin Systems AB is a growing organisation, supported by an expert advisory board, dedicated to the development of EbsArgentTM as a new solution to antimicrobial resistance.


Mohamad Takwa, PhD

Business Advisor | +46 72-322 22 21

Mohamad holds a PhD in biotechnology from the Royal Institute of Technology (KTH) in Stockholm. Mohamad has co-founded several successful biotech and cleantech start-ups, like Thyrolytics, Spermosens, Avsalt and Viraspec. He is also experienced in the journey from early start-up to listed company, as he co-founded and developed Bioextrax AB (publ).

Carlos Ratia Loncán, PhD

Lab Manager

Carlos is a clinical microbiologist and holds a PhD from the University of Barcelona, with long experience from researching novel antibiotics against MDR pathogens.

Isak Edvardsson

Business Developer & Administrator

Isak is a business administrator with a degree from Lund University School of Economics and Management and has experience from several early-stage companies.


Mikael Thomsen, PhD

External advisor

Dr. Mikael Thomsen is an expert drug developer with a PhD in Pharmacology & Toxicology and has more than 25 years’ experience from the pharmaceutical industry. Mikael has worked at Novartis Pharma, Novo Nordisk and the U.S. Food and Drug Administration. Mikael has held the roles of Chief Development Officer, Chief Scientific Officer and Head of R&D at various European biotech companies and has co-founded several companies himself.

Helen Steel, MD

External advisor

Dr. Helen Steel is a pharmaceutical industry expert with extensive experience in infectious diseases R&D. She was a Director of Clinical Development at GlaxoSmithKline for 15 years, and later became the Head Unit Physician for the Infectious Diseases Therapeutic Area. She has also led a global team of pharmacovigilance professionals in her position as Head of Shared Safety Sciences. Helen has nearly 30 years’ experience in the pharmaceutical development industry.